Our study uncovers a detailed mechanism that attenuates IL-17 expression via ROR-γt SUMOylation, which holds therapeutic potential for clinically boosting IL-17 immunity against pathogens or preventing pathological Th17-mediated autoimmunity by controlling the ROR-γt/IL-17 pathways. Here, IL17A is linked to Autoimmunity.